Xeriant, Inc. announced the signing of a joint venture agreement with Movychem s.r.o. (Movychem). The definitive agreement establishes a U.S.-based partnership between Xeriant and Movychem, structured as a 50/50 joint venture, which has acquired the exclusive worldwide rights to the internationally patented, eco-friendly Retacell® fire retardant technology and is responsible for developing applications and commercializing products derived from Retacell®. The establishment of the joint venture is the culmination of several months of negotiations, which included a series of meetings in December 2021 held in the Czech Republic.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0249 USD | +18.57% | -17.00% | +40.68% |
1st Jan change | Capi. | |
---|---|---|
+40.68% | 12.54M | |
+25.65% | 140B | |
+14.02% | 81.1B | |
-4.62% | 66.08B | |
+24.87% | 52.66B | |
+50.62% | 48.07B | |
+4.06% | 41.57B | |
+77.38% | 39.95B | |
+60.84% | 25.5B | |
+82.02% | 24.32B |
- Stock Market
- Equities
- XERI Stock
- News Xeriant, Inc.
- Xeriant Signs Joint Venture Agreement with Movychem